October 19-22, 2023
Hilton Minneapolis
Minneapolis, Minnesota  

Sign Up for Additional Information

Conference Cochairs:

Nada Jabado, McGill University, Montréal, QC, Canada
Jeremy N. Rich, University of Pittsburgh, Pittsburgh, Pennsylvania
Michael D. Taylor, Texas Children’s Hospital, Baylor College of Medicine, Houston, Texas

Despite decades of research, primary and secondary brain cancers remain complex areas of oncology, with brain tumors being among the deadliest of all cancers. Because of the distinct biological characteristics of neural tissues, brain tumors are difficult to treat, resisting almost all conventional and novel treatments. Glioblastoma, the most lethal form of brain cancer, kills more than two-thirds of adults within two years of diagnosis, and brain malignancies are the most common and lethal among all pediatric solid tumors. The goal of this conference is to integrate rapidly evolving advances in cancer therapy to gain a more in-depth understanding of the unique environment of brain tumors and develop novel therapeutic and prevention strategies for both primary and secondary brain cancers. In addition to highlighting new approaches, innovative ideas, and recent advances in brain cancer research, there will also be opportunities for collaboration and idea exchange among those dedicated to the science and care of patients with brain cancer.